ASAM Pocket Guidelines and Patient Guide

Stimulant Use Disorder

ASAM Opioid Addiction Treatment GUIDELINES Apps and Pocket Guides brought to you courtesy of Guideline Central. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1519511

Contents of this Issue

Navigation

Page 27 of 29

28 Treatment Harm Reduction Harm Reduction Education 84. For patients who engage in risky stimulant use, clinicians should: a. offer basic harm reduction education about safer stimulant use (L-S), b. tailor harm reduction education to the patient's patterns of substance use (eg, context of use, route of administration, type of preparation; L-S), c. refer to relevant local harm reduction services as indicated based on the patient's clinical assessment (L-S), d. offer harm reduction education on overdose prevention and reversal (H-S), and e. offer harm reduction education regarding safer sexual practices (H-S). Overdose Prevention and Reversal 85. For patients who use stimulants from nonmedical sources or are socially engaged with others who do, clinicians should prescribe or distribute overdose reversal medications (eg, naloxone) or refer patients to locations where they can obtain these medications in the community (H-S). Note: There is an increased concern regarding fentanyl contamination and as a result, opioid-related overdose. 86. Clinicians should recommend that patients perform comprehensive drug checking, including using fentanyl test strips, every time they obtain a new batch of stimulants from nonmedical sources and review the technique for using fentanyl test strips when permitted by state law (M-C). 87. Clinicians should consider referring individuals to local supervised consumption sites (SCS) when available (M-S). Safer Sexual Practices and Contraception 88. For patients who engage in risky sexual behaviors, clinicians should: a. offer or refer for STI testing at least every 3 to 6 months or more frequently depending on the individual patient's risk (M-S); i. consider providing information about local STI testing services where patients can obtain free or low-cost testing (M-S); b. consider offering a referral to a local psychosocial sex education program or harm reduction program that addresses risky sexual behavior for additional or continuing harm reduction intervention (L-S); and c. offer condoms and lubrication or advice about where to obtain them (CC-S).

Articles in this issue

view archives of ASAM Pocket Guidelines and Patient Guide - Stimulant Use Disorder